RGCC Screening

RGCC Cancer Screening Early Detection. Tailored Therapies. Ongoing Monitoring.

WHAT ARE GCC CANCER TESTS

Gain Deeper Insight Into Cancer Risk and Personalised Treatment Options

RGCC cancer screenings offer some of the most advanced blood-based testing available for detecting and monitoring cancer.

Through a simple blood sample, these tests analyse circulating tumour cells (CTCs), cancer stem cells, and genetic markers - providing detailed insights into cancer presence, progression, and treatment responsiveness.

The ability to detect cancer-related activity at early stages makes RGCC testing a powerful tool for diagnosis, treatment planning, and long-term cancer monitoring.

OVERVIEW OF RGCC TESTS

Which RGCC Test Is Right for You?

Each RGCC test offers unique insights to support cancer prevention, personalised treatment, or ongoing monitoring.

RGCC Immune Frame

Provides a detailed analysis of your immune system status, helping to identify potential immune imbalances or dysfunction that may influence cancer risk, progression, or treatment response. Ideal for patients looking to optimise immune health as part of an integrative cancer approach.

RGCC aCGH Test

An advanced genetic screening that detects copy number variations (CNVs) across the entire genome, helping identify genetic abnormalities linked to cancer development, progression, or resistance to treatment.

Onco D-CLARE by RGCC

A highly sensitive blood test designed for early cancer screening, detecting circulating tumour cells (CTCs) to provide an early indication of possible cancer presence before conventional imaging can reveal it.

OncoTrace by RGCC

Monitors circulating tumour cells (CTCs) to assess cancer progression or residual disease. Useful for patients with known cancer or those in remission seeking ongoing monitoring to detect potential recurrence.

RGCC Onconomics Panels

Combines CTC analysis with in vitro chemosensitivity and natural substance testing, helping clinicians personalise cancer treatment by identifying which chemotherapy drugs and natural agents are most effective against a patient’s specific tumour cells.

RGCC Oncotrail

Designed for monitoring specific types of cancer (such as breast, prostate, colon), this test tracks circulating tumour cells and tumour markers relevant to a particular cancer type, supporting tailored disease management and monitoring.

RGCC CANCER TESTS

Explore Our Range of Advanced RGCC Tests

Our RGCC test portfolio includes the following options:

Book a Consultation Book a Consultation